A pilot study in hair regrowth with local injection of platelet rich plasma in patients with alopecia areata

Assessment of platelet rich plasma effect on the treatment of chronic alopecia areata

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2013010612031N1

Enrollment

Registered

2013-02-15

Start date

2011-09-01

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alopecia areata totalis. Alopecia areata

Interventions

Intervention 1: Intervention: Injection of platelet rich plasma. Intervention 2: Control: no treatment.

Treatment - Drugs

Intervention: Injection of platelet rich plasma

Control: no treatment

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria: equal or over 18 years old; clinically diagnosed as alopecia areata totalis; at least 3 years of this illness; no treatment during last 3 months. Exclusion criteria: current and history of malignancy in the body; current benign tumors; hemorrhagic disorders; platelet count below 100000/ml; pregnancy; lactation; and if the patient cannot continue the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Local side effect. Timepoint: One week after injection. Method of measurement: Inspection.	—

Secondary

Measure	Time frame
Hair regrowth. Timepoint: 20 weeks after injection. Method of measurement: SALT score.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZohreh Tehranchinia

skin research center of Shohada-e-Tajrish hospital

Zohreh_ tehranchi@yahoo.com+98 21 2274 1507

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026